[go: up one dir, main page]

FI950818L - Nya substituerade sulfonamider, förfarande för deras framställning oc farmaceutiska kompositioner, som innehåller dessa föreningar - Google Patents

Nya substituerade sulfonamider, förfarande för deras framställning oc farmaceutiska kompositioner, som innehåller dessa föreningar Download PDF

Info

Publication number
FI950818L
FI950818L FI950818A FI950818A FI950818L FI 950818 L FI950818 L FI 950818L FI 950818 A FI950818 A FI 950818A FI 950818 A FI950818 A FI 950818A FI 950818 L FI950818 L FI 950818L
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
novel substituted
substituted sulfonamides
Prior art date
Application number
FI950818A
Other languages
English (en)
Finnish (fi)
Other versions
FI110364B (sv
FI950818A0 (sv
Inventor
Jean-Louis Peglion
Jean-Paul Vilaine
Nicole Villeneuve
Jean-Pierre Iliou
Jean-Pierre Bidouard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of FI950818A0 publication Critical patent/FI950818A0/sv
Publication of FI950818L publication Critical patent/FI950818L/sv
Application granted granted Critical
Publication of FI110364B publication Critical patent/FI110364B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/66Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
FI950818A 1994-02-25 1995-02-22 Nya substituerade sulfonamider och farmaceutiska kompositioner, som innehåller dessa föreningar FI110364B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9402159A FR2716679B1 (fr) 1994-02-25 1994-02-25 Nouvelles sulfonamides substituées, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR9402159 1994-02-25
US08/393,452 US5565457A (en) 1994-02-25 1995-02-23 Substituted sulfonamides
US39345295 1995-02-23

Publications (3)

Publication Number Publication Date
FI950818A0 FI950818A0 (sv) 1995-02-22
FI950818L true FI950818L (sv) 1995-08-26
FI110364B FI110364B (sv) 2002-12-31

Family

ID=26230972

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950818A FI110364B (sv) 1994-02-25 1995-02-22 Nya substituerade sulfonamider och farmaceutiska kompositioner, som innehåller dessa föreningar

Country Status (16)

Country Link
US (1) US5565457A (sv)
EP (1) EP0669322B1 (sv)
JP (1) JPH07258217A (sv)
CN (1) CN1053895C (sv)
AT (1) ATE184597T1 (sv)
AU (1) AU682428B2 (sv)
CA (1) CA2143249C (sv)
DE (1) DE69512104T2 (sv)
DK (1) DK0669322T3 (sv)
ES (1) ES2139156T3 (sv)
FI (1) FI110364B (sv)
FR (1) FR2716679B1 (sv)
GR (1) GR3031256T3 (sv)
NO (1) NO302571B1 (sv)
NZ (1) NZ270567A (sv)
ZA (1) ZA951577B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
FR2804429B1 (fr) * 2000-01-31 2003-05-09 Adir Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2439634A1 (en) * 2001-03-01 2002-09-12 Technological Resources Pty Limited Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
JPWO2004092136A1 (ja) * 2003-04-18 2006-07-06 小野薬品工業株式会社 含窒素複素環化合物およびその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527768A (en) * 1967-11-24 1970-09-08 Monsanto Co Sulfonamido coumarin compounds
JP2556722B2 (ja) * 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
EP0525203A4 (en) * 1991-02-13 1994-07-06 Asahi Chemical Ind Substituted sulfonamide derivative or pharmaceutical composition containing the same

Also Published As

Publication number Publication date
DE69512104T2 (de) 2000-04-20
CN1053895C (zh) 2000-06-28
FR2716679A1 (fr) 1995-09-01
EP0669322B1 (fr) 1999-09-15
ATE184597T1 (de) 1999-10-15
AU1344995A (en) 1995-09-07
FI110364B (sv) 2002-12-31
DK0669322T3 (da) 2000-03-27
CA2143249C (fr) 2002-02-26
ZA951577B (en) 1995-12-12
GR3031256T3 (en) 1999-12-31
CA2143249A1 (fr) 1995-08-26
DE69512104D1 (de) 1999-10-21
NO302571B1 (no) 1998-03-23
NO950716L (no) 1995-08-28
CN1120537A (zh) 1996-04-17
ES2139156T3 (es) 2000-02-01
FI950818A0 (sv) 1995-02-22
EP0669322A1 (fr) 1995-08-30
FR2716679B1 (fr) 1996-04-05
NZ270567A (en) 1996-05-28
US5565457A (en) 1996-10-15
NO950716D0 (no) 1995-02-24
AU682428B2 (en) 1997-10-02
JPH07258217A (ja) 1995-10-09

Similar Documents

Publication Publication Date Title
FI955024A7 (sv) Nya piperidinföreningar, förfarande för deras framställning och farmaceutiska kompositioner som innehåller dessa föreningar
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
FI973148A7 (sv) Substituerade heterocykliska föreningar, förfarande för deras framstäl lning och farmaceutiska kompositioner innehållande dessa
FI973039A0 (sv) Nya farnecyltransferasinhibitorer, deras framställning och dessa innehållande farmaceutiska kompositioner
FI973279A0 (sv) Nya farnecyltransferasinhibitorer, framställning av dem och dessa innehållande farmaceutiska kompositioner
FI954304L (sv) Nya bensopyranderivat, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dessa föreningar
FI972309A0 (sv) 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning
FI952550A7 (sv) Nya N-pyridylkarboxamider och derivat, förfaranden för deras framställning och farmaceutiska kompositioner, som innehåller dessa föreningar
FI943688L (sv) Nya 11-bensaldoxim-17beta-metoxi-17alfa-metoximetyl-estradienderivat, förfaranden för framställning av desamma och läkemedel innehållande dessa föreningar
FI930974A7 (sv) Substituerade aminofosfonatderivat, förfarande för framställning av desamma och farmaceutiska kompositioner innehållande desamma
FI941836A7 (sv) 3-deoxioligosackarider, förfaranden för framställning av dessa och farmaceutiska kompositioner innehållande dessa
FI943645L (sv) Nya backatin-III och 10-deacetylbackatin-III-derivat, framställning av dem och dessa innehållande farmaceutiska kompositioner
FI953384L (sv) Ny bensotiadiazinförening, förfarande för dess framställning och farmaceutiska kompositioner, som innehåller denna förening
FI956278A0 (sv) Substituerade 4-fenyltiazolderivat, förfarande för deras framställnin g och farmaceutiska kompositioner innehållande dem
FI950817A7 (sv) Nya bensodioxanföreningar, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dessa föreningar
FI960316L (sv) Oxatiolaner, förfarande för deras framställning och farmaceutiska kompositioner innehållande desamma
FI953308A7 (sv) Nya bensopyranföreningar, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dessa föreningar
FI955085L (sv) Nya diosmetinföreningar, förfarande för deras framställning och farmaceutiska kompositioner som innehåller dessa föreningar
FI963440A7 (sv) Nya aminosyraderivat, förfarande för deras framställning och dessa för eningar innehållande farmaceutiska blandningar
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI951297L (sv) Nya aminoalkyl-bensoxazolinoner och -bensotiazolinoner, förfarande för deras framställning och farmaceutiska kompositioner som innehåller dessa föreningar
FI951091L (sv) Nya alkylaminoindanföreningar, förfaranden för deras framställning samt farmaceutiska kompositioner, som innehåller dessa föreningar
FI950818L (sv) Nya substituerade sulfonamider, förfarande för deras framställning oc farmaceutiska kompositioner, som innehåller dessa föreningar
FI922773A7 (sv) Nya p-substituerade fenyl-4-oksibutanaminderivat, förfarande för deras framställning samt farmaseutiska kompositioner innehållande desamma
FI944751L (sv) Heteroarylpiperidiner, förfarande för deras framställning och farmaceutiska kompositioner som innehåller dessa

Legal Events

Date Code Title Description
MA Patent expired